80374 Stereoisomer analysis
Also known as: stereoisomer analysis, chiral drug assay
Drug screen with stereoisomer analysis, determining the specific stereochemical configuration of drug molecules for enhanced identification.
In Plain Language
detailed drug structure test
Clinical Context
Used in forensic toxicology and complex drug identification cases where stereoisomer differentiation is critical.
RVU Information
CPT 80374 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 80374?
CPT 80374 (Stereoisomer analysis) is a Pathology & Lab code. Drug screen with stereoisomer analysis, determining the specific stereochemical configuration of drug molecules for enhanced identification.
Who uses CPT code 80374?
CPT 80374 is used by Toxicology, Forensic Pathology, Laboratory Medicine. Used in forensic toxicology and complex drug identification cases where stereoisomer differentiation is critical.
When is CPT 80374 used?
Used in forensic toxicology and complex drug identification cases where stereoisomer differentiation is critical.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.